Literature DB >> 16436059

Effects of sterol biosynthesis inhibitors on endosymbiont-bearing trypanosomatids.

Isabella Vieira Palmié-Peixoto1, Marcia Rosa Rocha, Julio A Urbina, Wanderley de Souza, Marcelo Einicker-Lamas, Maria Cristina Machado Motta.   

Abstract

Some protozoa of the Trypanosomatidae family have a close relationship with an endosymbiotic bacterium. As the prokaryote envelope has a controversial origin, a sterol 24-methyltransferase inhibitor (20-piperidin-2-yl-5alpha-pregnan-3beta,20-diol; 22,26-azasterol) was used as a tool to investigate lipid biosynthetic pathways in Crithidia deanei, an endosymbiont-bearing trypanosomatid. Apart from antiproliferative effects, this drug induced ultrastructural alterations, consisting of myelin-like figures in the cytoplasm and endosymbiont envelope vesiculation. Concurrently, a dramatic reduction of 24-alkyl sterols was observed after 22,26-azasterol treatment, both in whole cell homogenates, as well as in isolated mitochondria. These effects were associated with changes of phospholipid composition, in particular a reduction of the phosphatidylcholine content and a concomitant increase in phosphatidylethanolamine levels. Lipid analyses of purified endosymbionts indicated a complete absence of sterols, and their phospholipid composition was different from that of mitochondria or whole protozoa, being similar to eubacteria closely associated with eukaryotes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436059     DOI: 10.1111/j.1574-6968.2005.00056.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.

Authors:  Juliany Cola Fernandes Rodrigues; Juan Luis Concepcion; Carlos Rodrigues; Aura Caldera; Julio A Urbina; Wanderley de Souza
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

2.  Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.

Authors:  S T de Macedo-Silva; G Visbal; J A Urbina; W de Souza; J C F Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

3.  Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis.

Authors:  Kelly Ishida; Juliany Cola Fernandes Rodrigues; Simon Cammerer; Julio A Urbina; Ian Gilbert; Wanderley de Souza; Sonia Rozental
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-01-21       Impact factor: 3.944

4.  Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis.

Authors:  Sara Teixeira de Macedo-Silva; Thais Larissa Araújo de Oliveira Silva; Julio A Urbina; Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Mol Biol Int       Date:  2011-06-13

5.  Growth inhibition and ultrastructural alterations induced by Delta24(25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans organisms.

Authors:  Kelly Ishida; Juliany Cola Fernandes Rodrigues; Marcos Dornelas Ribeiro; Taíssa Vieira Machado Vila; Wanderley de Souza; Julio A Urbina; Celso Vataru Nakamura; Sonia Rozental
Journal:  BMC Microbiol       Date:  2009-04-20       Impact factor: 3.605

6.  Endosymbiosis in trypanosomatids: the genomic cooperation between bacterium and host in the synthesis of essential amino acids is heavily influenced by multiple horizontal gene transfers.

Authors:  João M P Alves; Cecilia C Klein; Flávia Maia da Silva; André G Costa-Martins; Myrna G Serrano; Gregory A Buck; Ana Tereza R Vasconcelos; Marie-France Sagot; Marta M G Teixeira; Maria Cristina M Motta; Erney P Camargo
Journal:  BMC Evol Biol       Date:  2013-09-09       Impact factor: 3.260

7.  Combining transcriptomics and metabolomics to reveal the underlying molecular mechanism of ergosterol biosynthesis during the fruiting process of Flammulina velutipes.

Authors:  Ruihong Wang; Pengda Ma; Chen Li; Lingang Xiao; Zongsuo Liang; Juane Dong
Journal:  BMC Genomics       Date:  2019-12-19       Impact factor: 3.969

8.  Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

Authors:  Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-05

9.  Predicting the proteins of Angomonas deanei, Strigomonas culicis and their respective endosymbionts reveals new aspects of the trypanosomatidae family.

Authors:  Maria Cristina Machado Motta; Allan Cezar de Azevedo Martins; Silvana Sant'Anna de Souza; Carolina Moura Costa Catta-Preta; Rosane Silva; Cecilia Coimbra Klein; Luiz Gonzaga Paula de Almeida; Oberdan de Lima Cunha; Luciane Prioli Ciapina; Marcelo Brocchi; Ana Cristina Colabardini; Bruna de Araujo Lima; Carlos Renato Machado; Célia Maria de Almeida Soares; Christian Macagnan Probst; Claudia Beatriz Afonso de Menezes; Claudia Elizabeth Thompson; Daniella Castanheira Bartholomeu; Daniela Fiori Gradia; Daniela Parada Pavoni; Edmundo C Grisard; Fabiana Fantinatti-Garboggini; Fabricio Klerynton Marchini; Gabriela Flávia Rodrigues-Luiz; Glauber Wagner; Gustavo Henrique Goldman; Juliana Lopes Rangel Fietto; Maria Carolina Elias; Maria Helena S Goldman; Marie-France Sagot; Maristela Pereira; Patrícia H Stoco; Rondon Pessoa de Mendonça-Neto; Santuza Maria Ribeiro Teixeira; Talles Eduardo Ferreira Maciel; Tiago Antônio de Oliveira Mendes; Turán P Ürményi; Wanderley de Souza; Sergio Schenkman; Ana Tereza Ribeiro de Vasconcelos
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.

Authors:  Sara Teixeira de Macedo-Silva; Julio A Urbina; Wanderley de Souza; Juliany Cola Fernandes Rodrigues
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.